Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07173088 · ClinicalTrials.gov registry record · NA

Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture

A NA study of Ankle Fractures, sponsored by Brian W. Noehren.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07173088: Recruiting NA study of Ankle Fractures, sponsored by Brian W. Noehren.

NCT07173088 is a NA study of Ankle Fractures that is actively recruiting participants, run by Brian W. Noehren. The registered enrollment target is 60 participants, below the 248-participant average among 12 other Ankle Fractures trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07173088, a NA study of Ankle Fractures, is actively recruiting participants, sponsored by Brian W. Noehren.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare two different standardized physical therapy rehabilitation programs on outcomes after an ankle fracture. Researchers will evaluate to see if the addition of ankle muscle power exercises (AMP) improve program adherence, muscle function, physical performance, and patient reported outcomes. The main questions it aims to answer are: 1. Assess feasibility and define the initial effects of the AMP program on ankle plantar flexor rate of torque development and ankle power. Primary hypothesis: an ankle muscle power program will have acceptable feasibility through assessment of 80% adherence, 90% treatment fidelity, recruitment (48 participants who complete the study), 80% retention, and 80% acceptability of the AMP program to facilitate clinical translation and the ability to scale-up the treatment. In addition ankle plantar flexor muscle power, plantar flexor RTD assessed isometrically, and ankle joint power, evaluated during gait and stair ascent/descent, will have significantly greater improvements in the AMP group than the standard of care group at the end of the intervention. 2. Test the effect of the AMP program on physical performance. Primary hypothesis: those completing the AMP program will have greater improvements in the 40 meter fast paced walk test and 11-stair climb test than those completing standard of care at the completion of the intervention. 3. Assess the preliminary efficacy of the AMP program on patient reported outcomes and quality of life. Primary hypothesis: compared to standard of care, the AMP program will result in improved quality of life on the ankle fracture outcome rehabilitation measure (A-FORM) Participants will complete rehabilitation and be assessed for outcomes at baseline and after completing the intervention. Additionally exploratory outcomes will be assessed 3 months after completing the intervention.

Primary Outcome

Adherence refers to the commitment of a participant to participate in the rehab. Adherence will be measured by calculating the number of rehab sessions attended divided by the number of rehab sessions possible.

Conditions Studied

Interventions

  • BEHAVIORAL Standard of Care
  • OTHER Ankle Muscle Power (AMP) program

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-11-13
Est. Completion 2028-03
Phase NA
Brian W. Noehren

3 total trials

What NCT07173088 shows while recruiting

NCT07173088 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 248-participant average among 12 other Ankle Fractures trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Ankle Fractures appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT07173088 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT07173088 about?

NCT07173088 is a clinical study titled "Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture". The goal of this clinical trial is to compare two different standardized physical therapy rehabilitation programs on outcomes after an ankle fracture. Researchers will evaluate to see if the addition of ankle muscle power exercises (AMP) improve program adherence, muscle function, physical performan...

What is the current status of trial NCT07173088?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-11-13. Estimated completion is 2028-03.

What conditions does trial NCT07173088 study?

This clinical trial studies the following conditions: Ankle Fractures.

What interventions are being tested in trial NCT07173088?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Ankle Muscle Power (AMP) program (OTHER).

Who is sponsoring clinical trial NCT07173088?

This trial is sponsored by Brian W. Noehren, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07173088 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ankle Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07173088's enrollment target sits among peer trials

60 7th of 12 higher than 6 of 12 other Ankle Fractures trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ankle Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07173088, the US trial registry maintained by the National Library of Medicine. NCT07173088 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.